Fig.1From: Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVERUse of SGLT2 inhibitors and GLP-1 receptor agonists by country. A Grouped by global region; B Ordered by gross national income per capitaBack to article page